Kevin M. Schlosser

Antitumor activity and pharmacokinetic properties of PF-00299804, a second-generation irreversible pan-erbB receptor tyrosine kinase inhibitor

Andrea J. Gonzales, Kenneth E. Hook, Irene W. Althaus et al. · Molecular Cancer Therapeutics · 2008 · 221 citations · Full text

Medicine, Oncology, Pharmacology +15

A Highly Efficient Procedure for 3-Sulfenylation of Indole-2-carboxylates

Kevin M. Schlosser, Alexei P. Krasutsky, Harriet W. Hamilton et al. · Organic Letters · 2004 · 166 citations

Natural Sciences, Chemistry, Green Chemistry +9

High-performance exclusion of schizophrenia using a novel machine learning method on EEG data

Ricardo Buettner, Michael Hirschmiller, Kevin M. Schlosser et al. · 2019 · 64 citations

Computing, Neuroscience, Psychiatry +16

Tyrosine Kinase Inhibitors. 20. Optimization of Substituted Quinazoline and Pyrido[3,4-<i>d</i>]pyrimidine Derivatives as Orally Active, Irreversible Inhibitors of the Epidermal Growth Factor Receptor Family

Jeff B. Smaill, Andrea J. Gonzales, Julie A. Spicer et al. · Journal of Medicinal Chemistry · 2016 · 60 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16